Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study)

Tocilizumab, a humanized monoclonal antibody to the interleukin 6 (IL-6) receptor, was approved for use as rheumatoid arthritis (RA) therapy in Japan in 2008, but its efficacy and tolerability in daily practice has not yet been reported. We report the results of a multicenter retrospective study on...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yamanaka, Hisashi, Tanaka, Yoshiya, Inoue, Eisuke, Hoshi, Daisuke, Momohara, Shigeki, Hanami, Kentaro, Yunoue, Naoki, Saito, Kazuyoshi, Amano, Kouichi, Kameda, Hideto, Takeuchi, Tsutomu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Japan 2010
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071926/
https://ncbi.nlm.nih.gov/pubmed/20953815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-010-0366-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi